文献速递神经肿瘤神经重症

原发性和继发性脑肿瘤患者生命终末期癫痫发作及癫痫持续状态发生率高

High end-of-life incidence of seizures and status epilepticus in patients with primary and secondary brain tumors.
PubMed 文献 · J Neurooncol · 2022-11-03

这项回顾性单中心研究纳入2015年1月至2020年8月住院期间或出院后7天内死亡的脑肿瘤患者68例,结合临床记录和死亡前45天内脑电图分析生命终末期癫痫发作发生率。50例(73.5%)在死亡前45天内出现癫痫发作,其中24例为癫痫持续状态。

要点

  • 68例脑肿瘤患者中50例(73.5%)在死亡前45天内出现癫痫发作。
  • 50例癫痫发作患者中24例为癫痫持续状态。
  • 45例通过临床表现诊断,5例通过脑电图检测到可能的非惊厥性癫痫持续状态诊断。

核心结论

  • 在具备神经科培训人员并频繁使用常规脑电图的条件下,能够识别癫痫发作并将癫痫持续状态与脑病/低活动性谵妄区分。
  • 神经肿瘤患者生命终末期癫痫发作和癫痫持续状态的发生率高于既往报告。

研究设计与样本

  • 回顾性单中心研究,纳入2015年1月至2020年8月期间在病房住院期间或出院后7天内死亡的脑肿瘤患者68例。
  • 分析源自原始病历的癫痫临床观察记录及死亡前45天内的脑电图结果。

主要发现

  • 68例符合条件的患者中,50例(73.5%)在死亡前45天内出现癫痫发作。
  • 50例癫痫发作患者中24例为癫痫持续状态。
  • 45例通过临床表现诊断癫痫发作/癫痫持续状态,5例通过脑电图检测到可能的非惊厥性癫痫持续状态而诊断。

关键数值与推荐

  • 原文报告生命终末期临床观察到的癫痫发作比例为6%至56%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Seizures pose a significant burden in patients with primary and secondary brain tumors during the end-of-life period. A wide range of 6 to 56% of clinically observed epileptic seizures at the end of life has been reported. We aimed to analyse the incidence of epileptic seizures at the end of life in brain tumor patients more accurately using not only clinical but also electrophysiological findings. METHODS: This retrospective, single center study included brain tumor patients who died during the stay on the ward or within 7 days after discharge between 01/2015 and 08/2020. Clinical observation of seizures derived from the original medical records and EEG findings (within 45 days prior to death) were analyzed to determine the incidence of seizures in that period. RESULTS: Of the 68 eligible patients, 50 patients (73.5%) suffered from seizures within 45 days prior to death, of which n = 24 had a status epilepticus. The diagnosis of seizures/ status epilepticus was determined either by the presentation of clinical signs in 45 patients and if not, by the detection of a (possible) non-convulsive status epilepticus in the EEG of five patients. CONCLUSION: In the presence of neurologically trained staff and with the frequent use of routine EEG, we were able to identify seizures and to distinguish status epilepticus from encephalopathy/ hypoactive delirium. We detected a higher incidence of seizures and status epilepticus at the end of life in neurooncological patients than previously reported.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Brauchitsch SV, Strzelczyk A, Rosenow F, et al. High end-of-life incidence of seizures and status epilepticus in patients with primary and secondary brain tumors. J Neurooncol. 2022. PMID: 36329367. doi:10.1007/s11060-022-04133-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。